These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38017101)

  • 1. Infographic: intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration (VIEW 1 and VIEW 2).
    Crisostomo KGR; Dantes JKPC; Magpantay DMM; Artiaga JCM
    Eye (Lond); 2024 Aug; 38(Suppl 2):49-50. PubMed ID: 38017101
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
    Heier JS; Brown DM; Chong V; Korobelnik JF; Kaiser PK; Nguyen QD; Kirchhof B; Ho A; Ogura Y; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Soo Y; Anderesi M; Groetzbach G; Sommerauer B; Sandbrink R; Simader C; Schmidt-Erfurth U;
    Ophthalmology; 2012 Dec; 119(12):2537-48. PubMed ID: 23084240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflibercept in wet AMD: specific role and optimal use.
    Semeraro F; Morescalchi F; Duse S; Parmeggiani F; Gambicorti E; Costagliola C
    Drug Des Devel Ther; 2013; 7():711-22. PubMed ID: 23990705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration.
    Yuzawa M; Fujita K; Wittrup-Jensen KU; Norenberg C; Zeitz O; Adachi K; Wang EC; Heier J; Kaiser P; Chong V; Korobelnik JF
    Ophthalmology; 2015 Mar; 122(3):571-8. PubMed ID: 25439429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflibercept in wet age-related macular degeneration: a perspective review.
    Ohr M; Kaiser PK
    Ther Adv Chronic Dis; 2012 Jul; 3(4):153-61. PubMed ID: 23342231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration.
    Stewart MW
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):103-13. PubMed ID: 23473589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab.
    Parikh R; Avery RL; Saroj N; Thompson D; Freund KB
    JAMA Ophthalmol; 2019 Aug; 137(8):914-920. PubMed ID: 31294771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
    Lukacs R; Schneider M; Nagy ZZ; Sandor GL; Kaan K; Asztalos A; Enyedi L; Pek G; Barcsay G; Szabo A; Borbandy A; Kovacs I; Resch MD; Papp A
    BMC Ophthalmol; 2023 Mar; 23(1):110. PubMed ID: 36932356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial.
    Zehetner C; Kralinger MT; Modi YS; Waltl I; Ulmer H; Kirchmair R; Bechrakis NE; Kieselbach GF
    Acta Ophthalmol; 2015 Mar; 93(2):e154-9. PubMed ID: 25488124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration.
    Johnston SS; Wilson K; Huang A; Smith D; Varker H; Turpcu A
    Adv Ther; 2013 Dec; 30(12):1111-27. PubMed ID: 24310208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration.
    Brown GC; Brown MM; Rapuano S; Boyer D
    Am J Ophthalmol; 2020 Oct; 218():225-241. PubMed ID: 32565050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflibercept for age-related macular degeneration: a game-changer or quiet addition?
    Browning DJ; Kaiser PK; Rosenfeld PJ; Stewart MW
    Am J Ophthalmol; 2012 Aug; 154(2):222-6. PubMed ID: 22813448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration.
    Papadopoulos Z
    Eur J Ophthalmol; 2019 Jul; 29(4):368-378. PubMed ID: 30813810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration.
    Kähkönen M; Tuuminen R; Aaltonen V
    BMC Ophthalmol; 2021 Aug; 21(1):312. PubMed ID: 34454473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.
    Yazdi MH; Faramarzi MA; Nikfar S; Falavarjani KG; Abdollahi M
    Expert Opin Biol Ther; 2015; 15(9):1349-58. PubMed ID: 26076760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.
    Park DH; Sun HJ; Lee SJ
    Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept.
    Nowosielska A
    Case Rep Ophthalmol; 2019; 10(3):369-373. PubMed ID: 31762770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration.
    Thomas M; Mousa SS; Mousa SA
    Clin Ophthalmol; 2013; 7():495-501. PubMed ID: 23503202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflibercept for intravitreal injection: in neovascular age-related macular degeneration.
    Frampton JE
    Drugs Aging; 2012 Oct; 29(10):839-46. PubMed ID: 23038609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.